Filed before 2025Filed 3 January 2022
Cytovale Inc. has sold $16.4M so far
Cytovale Inc., a biotech company based in San Francisco, CA, has sold $16.4M so far in its debt round, according to a filing dated 3 January 2022.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 3 January 2022
- First filed
- 4 January 2021
- Round
- Debt round (amended filing)
- Amount sold
- $16.4M
- Offering size
- $20M
- Investors so far
- 23
- Based in
- San Francisco, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 65% of the 1,764 tracked raises with an amount filed in 2022, and than 62% of the 142 in biotech.
Cytovale Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 3 Jan 2022 | Amended filing | $16.4M | This raise |
| 4 Jan 2021 | New filing | $8.01M | This raise |
| 30 Oct 2019 | New filing | $7.43M | Another raise |
| 26 Dec 2017 | New filing | $7.25M | Another raise |
More with Breakout Ventures on the board
- AquaPoro Technologies, Inc.$6.33M
- Vitra Labs, Inc.$8M
- Copernic Catalysts, Inc.$6.78M
- Immusoft Corp$4.58M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.